Therapy Targeting Antigen-Specific T Cells by a Peptide-Based Tolerizing Vaccine against Autoimmune Arthritis

Scientists showed that the administration of exogenous mouse major histocompatibility complex class II protein bounding a unique galactosylated collagen type II peptide directly interacted with the antigen-specific T cell receptor through a positively charged tag.